Karice K Hyun1, Julie Redfern1, Anushka Patel1, David Peiris1, David Brieger2, David Sullivan3, Mark Harris4, Tim Usherwood1,5, Stephen MacMahon1,6, Marilyn Lyford1,7, Mark Woodward1,6. 1. The George Institute for Global Health, Sydney Medical School, University of Sydney, Sydney, Australia. 2. Department of Cardiology, Concord Hospital, University of Sydney, Sydney, Australia. 3. Department of Chemical Pathology, Royal Prince Alfred Hospital, Sydney, Australia. 4. Centre for Primary Health Care and Equity, University of New South Wales, Sydney, Australia. 5. Sydney Medical School Westmead, University of Sydney, Sydney, Australia. 6. The George Institute for Global Health, University of Oxford, Oxford, UK. 7. WA Centre for Rural Health, University of Western Australia, Perth, Australia.
Abstract
OBJECTIVES: To quantify contemporary differences in cardiovascular disease (CVD) risk factor assessment and management between women and men in Australian primary healthcare services. METHODS: Records of routinely attending patients were sampled from 60 Australian primary healthcare services in 2012 for the Treatment of Cardiovascular Risk using Electronic Decision Support study. Multivariable logistic regression models were used to compare the rate of CVD risk factor assessment and recommended medication prescriptions, by gender. RESULTS: Of 53 085 patients, 58% were female. Adjusting for demographic and clinical characteristics, women were less likely to have sufficient risk factors measured for CVD risk assessment (OR (95% CI): 0.88 (0.81 to 0.96)). Among 13 294 patients (47% women) in the CVD/high CVD risk subgroup, the adjusted odds of prescription of guideline-recommended medications were greater for women than men: 1.12 (1.01 to 1.23). However, there was heterogeneity by age (p <0.001), women in the CVD/high CVD risk subgroup aged 35-54 years were less likely to be prescribed the medications (0.63 (0.52 to 0.77)), and women in the CVD/high CVD risk subgroup aged ≥65 years were more likely to be prescribed the medications (1.34 (1.17 to 1.54)) than their male counterparts. CONCLUSIONS: Women attending primary healthcare services in Australia were less likely than men to have risk factors measured and recorded such that absolute CVD risk can be assessed. For those with, or at high risk of, CVD, the prescription of appropriate preventive medications was more frequent in older women, but less frequent in younger women, compared with their male counterparts. TRIAL REGISTRATION NUMBER: 12611000478910, Pre-results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
OBJECTIVES: To quantify contemporary differences in cardiovascular disease (CVD) risk factor assessment and management between women and men in Australian primary healthcare services. METHODS: Records of routinely attending patients were sampled from 60 Australian primary healthcare services in 2012 for the Treatment of Cardiovascular Risk using Electronic Decision Support study. Multivariable logistic regression models were used to compare the rate of CVD risk factor assessment and recommended medication prescriptions, by gender. RESULTS: Of 53 085 patients, 58% were female. Adjusting for demographic and clinical characteristics, women were less likely to have sufficient risk factors measured for CVD risk assessment (OR (95% CI): 0.88 (0.81 to 0.96)). Among 13 294 patients (47% women) in the CVD/high CVD risk subgroup, the adjusted odds of prescription of guideline-recommended medications were greater for women than men: 1.12 (1.01 to 1.23). However, there was heterogeneity by age (p <0.001), women in the CVD/high CVD risk subgroup aged 35-54 years were less likely to be prescribed the medications (0.63 (0.52 to 0.77)), and women in the CVD/high CVD risk subgroup aged ≥65 years were more likely to be prescribed the medications (1.34 (1.17 to 1.54)) than their male counterparts. CONCLUSIONS:Women attending primary healthcare services in Australia were less likely than men to have risk factors measured and recorded such that absolute CVD risk can be assessed. For those with, or at high risk of, CVD, the prescription of appropriate preventive medications was more frequent in older women, but less frequent in younger women, compared with their male counterparts. TRIAL REGISTRATION NUMBER: 12611000478910, Pre-results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Casey E Cavanagh; Lindsey Rosman; Philip W Chui; Lori Bastian; Cynthia Brandt; Sally Haskell; Matthew M Burg Journal: Health Psychol Date: 2020-01-30 Impact factor: 4.267
Authors: Bradley S Lander; Aimee M Layton; Robert P Garofano; Allan Schwartz; David J Engel; Natalie A Bello Journal: Am J Cardiol Date: 2021-11-26 Impact factor: 2.778
Authors: Zeynep Or; Kosta Shatrov; Anne Penneau; Walter Wodchis; Olukorede Abiona; Carl Rudolf Blankart; Nicholas Bowden; Enrique Bernal-Delgado; Hannah Knight; Luca Lorenzoni; Alberto Marino; Irene Papanicolas; Kristen Riley; Leila Pellet; Francisco Estupiñán-Romero; Kees van Gool; Jose F Figueroa Journal: Health Serv Res Date: 2021-08-19 Impact factor: 3.402
Authors: Keva Garg; Toral R Patel; Arjun Kanwal; Todd C Villines; Niti R Aggarwal; Khurram Nasir; Roger S Blumenthal; Michael J Blaha; Pamela S Douglas; Leslee J Shaw; Garima Sharma Journal: J Cardiovasc Comput Tomogr Date: 2021-10-08
Authors: Silvio E Inzucchi; Kamlesh Khunti; David H Fitchett; Christoph Wanner; Michaela Mattheus; Jyothis T George; Anne Pernille Ofstad; Bernard Zinman Journal: J Clin Endocrinol Metab Date: 2020-09-01 Impact factor: 5.958